PL308307A1 - 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations - Google Patents

3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations

Info

Publication number
PL308307A1
PL308307A1 PL93308307A PL30830793A PL308307A1 PL 308307 A1 PL308307 A1 PL 308307A1 PL 93308307 A PL93308307 A PL 93308307A PL 30830793 A PL30830793 A PL 30830793A PL 308307 A1 PL308307 A1 PL 308307A1
Authority
PL
Poland
Prior art keywords
oxyindolo
carboxylamide
substituted
pharmaceutical preparations
preparations
Prior art date
Application number
PL93308307A
Other versions
PL174170B1 (en
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL308307A1 publication Critical patent/PL308307A1/en
Publication of PL174170B1 publication Critical patent/PL174170B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL93308307A 1992-10-07 1993-09-02 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations PL174170B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07
PCT/US1993/008063 WO1994007488A1 (en) 1992-10-07 1993-09-02 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PL308307A1 true PL308307A1 (en) 1995-07-24
PL174170B1 PL174170B1 (en) 1998-06-30

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308307A PL174170B1 (en) 1992-10-07 1993-09-02 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387A (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
SK51296A3 (en) * 1995-04-24 1997-04-09 Pfizer Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength

Also Published As

Publication number Publication date
MY109680A (en) 1997-04-30
MX9306222A (en) 1994-04-29
WO1994007488A1 (en) 1994-04-14
ZA937405B (en) 1995-04-06
AU4839293A (en) 1994-04-26
NZ256164A (en) 1997-03-24
NO951350D0 (en) 1995-04-06
JPH07507809A (en) 1995-08-31
IL107122A (en) 1998-08-16
HU9302821D0 (en) 1993-12-28
CZ87895A3 (en) 1995-10-18
EG20289A (en) 1998-07-30
HUT68533A (en) 1995-04-27
PL174170B1 (en) 1998-06-30
RU2119353C1 (en) 1998-09-27
EP0662831A1 (en) 1995-07-19
IL107122A0 (en) 1993-12-28
CN1089138A (en) 1994-07-13
CZ282702B6 (en) 1997-09-17
KR950703338A (en) 1995-09-20
TW438798B (en) 2001-06-07
CA2146448A1 (en) 1994-04-14
FI934387A (en) 1994-04-08
NO951350L (en) 1995-06-06
FI934387A0 (en) 1993-10-06
AU676200B2 (en) 1997-03-06
JP2721042B2 (en) 1998-03-04
BR9307182A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
IL139235A0 (en) Pharmaceutical preparations
AU656157B2 (en) Pharmaceutical agents
PL320856A1 (en) Aerosol drug preparations
GB2272375B (en) Pharmaceutical composition
HU9300804D0 (en) Pharmaceutical preparatives
AU8072691A (en) Pharmaceutical preparations
GB9201639D0 (en) Pharmaceutical formulations
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
ZA934523B (en) Medicinal preparation
GB9216102D0 (en) Pharmaceutical substances
GB9213013D0 (en) Pharmaceutical preparation based on tretinon
PL298159A1 (en) Pharmaceutical preparation
ZA924111B (en) Pharmaceutical preparations
GB9014354D0 (en) Pharmaceutical preparations
GB9014364D0 (en) Pharmaceutical preparations
GB9014365D0 (en) Pharmaceutical preparations
GB9014367D0 (en) Pharmaceutical preparations
IE901759L (en) Pharmaceutical preparations
GB9221694D0 (en) Pharmaceutical formulation
GB9212968D0 (en) Pharmaceutical formulation
GB9221244D0 (en) Pharmaceutical formulations
GB9207989D0 (en) Pharmaceutical formulations
GB9204774D0 (en) Pharmaceutical formulations
GB9207338D0 (en) Pharmaceutical formulations